Definition
US FDA substance register · UNII 9W0D6VB8FH · registered name LITHIUM MYRISTATE · single chemical substance
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
Other restriction: ban substances that deplete the ozone layer
Source: EU CosIng ingredient list
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 20336-96-3
- EC No.EU chemical inventory number
- 243-743-8
- DTXSIDUS EPA chemical ID
- DTXSID9066596
- DTXCIDUS EPA compound ID
- DTXCID5036264
- IUPAC
- Lithium tetradecanoate
- Molecular formula
- C14H27LiO2
- Molecular weight
- 234.31 g/mol
What products actually use it for
What the 5 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Crystal growth modifiers (nucleating agents)2
- Stabilizing agent1
- Processing aids not otherwise specified1
- Emulsifier1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
8 skin studies and 3 eye studies are on record.
The studies disagree (the most common conclusion covers 11%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 11 studies
- Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) Magnusson and Kligman - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) Magnusson and Kligman (1969) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) - Studies Indicate No Significant Irritation
skin corrosion: in vitro / ex vivo · Screening · other guideline: OECD Guideline 439 (In Vitro Skin Irritation) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Ambiguous
skin corrosion: in vitro / ex vivo · Screening · EU Method B.40 (In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER)) according to other guideline: OECD GUIDELINE FOR THE TESTING OF CHEMICALS 431 according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
Source: US EPA CompTox dashboard